The expression of BCL2 in the primordial reserve both in patients that had or had not received chemotherapy rules out the possibility that BCL2 expression may be linked to a chemo-treatment response, supporting the idea that it is related to the presence of an extragonadal tumor. This evidence concerns the gene BCL2 and neoplasm.